Nanoexpo sp. z o.o.

Manufacture of other chemical products n.e.c.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2020-09-09
Share capital
5,000.00 PLN
Activity description

Nanoexpo is a biotech start-up that provides R&D services in bioengineering, specifically focusing on the design and manufacturing of enveloped and non-enveloped virus-like particles (VLPs). The company also offers services for producing polyclonal antibodies and designing antigens for vaccine development and diagnostic tests using various cell-based platforms. Additionally, they work with biological nanostructures capable of carrying genetic material.

Registered address
ul. Kładki 24/P.54, 80-822 Gdańsk, Poland
Email
Phone
Social media

Financials

Revenue history (in k)

From the notes

Loans and borrowings$41,412

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 254 days for 2024).

  • 202504/08/2026
  • 202426/03/2026
  • 202318/07/2024
  • 202213/07/2023
  • 202106/10/2022
  • 202008/04/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 72%
Sector · Manufacturing19,176 / 24,548
Top 78%
City · Gdańsk4,474 / 7,502
Top 60%
Voivodeship · Pomorskie12,702 / 20,062
Top 63%
Country · Poland186,774 / 297,069
Top 63%

Results vs industry

Revenue
This companyUSD 121.84kMedianUSD 638.23kAverageUSD 9.43m
Net profit
This companyUSD 56.90kMedianUSD 6.31kAverageUSD 97.67k
Operating costs
This companyUSD 60.79kMedianUSD 636.51kAverageUSD 9.00m
Assets
This companyUSD 145.75kMedianUSD 556.61kAverageUSD 6.76m

Offer

  • Biotechnology research and development services
  • Biological nanostructure design
  • Virus-like particle production
  • Antigen design
  • Polyclonal antibody production
  • Laboratory services

Websites

  • nanoexpo.euNaNoEXPO – terapie nowej generacji
    Google AnalyticsGoogle Tag ManagerApache

Authorized Representatives

Beata Marta Gromadzka age 47 – President of the Management Board
Mirosława Małgorzata Panasiuk age 40 – Management Board Member

Manner of representation

In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
51$688.8251%
40$540.2540%
Others
9$121.569%

Beneficial owners

Person

Subsidiaries

NameStake
Hybridovax sp. z o.o.
40%

Bank accounts

Registered as a VAT taxpayer on 2021-11-27.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid for research and development projects: industrial research
$80,175
Aid for research and development projects: industrial research
$171.1K
Aid for research and development projects: experimental development
$141.7K

European Funds

ProjectEU co-financing
Application of modern biotechnological and bioinformatic techniques to develop virus-like particles for diagnostic and therapeutic purposes.
$1.2M

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Vaxican sp. z o.o.
Medicofarma Biotech S.A.
Bioactive-Tech sp. z o.o.
Phage Consultants sp. z o.o.
Biotts S.A.
Cofactor sp. z o.o.
Awtm sp. z o.o.
Rebread Alcohol & Beverages sp. z o.o.
Personather sp. z o.o.
Fly-Gen sp. z o.o.

FAQ

Last updated: 2026-08-06